Ross Lobato Launches Body Evolution Labs: A New Era of Science-Backed Weight Loss and Body Contouring in Layton, Utah
Layton, UT - Ross Lobato, alongside his wife Shawna Stanger Lobato, proudly announces the opening of Body Evolution Labs, a premier medical spa in Davis County dedicated to transformative, non-invasive weight loss and body sculpting solutions.
Located at 1454 N Hill Field Rd, Suite #1, Body Evolution Labs offers a range of services designed to help clients achieve their health and aesthetic goals. The clinic specializes in FDA-approved GLP-1 weight loss programs utilizing Semaglutide and Tirzepatide, which have been shown to help clients lose 15–20% of their body weight. bodyevolution-labs.com+1tiktok.com+1
"We combine medical insight with real-life results," says Ross Lobato. "No gimmicks, no shortcuts—just proven treatments and personalized care that put your goals front and center." bodyevolution-labs.com
Services Offered:
GLP-1 Weight Loss Programs: Personalized plans using Semaglutide and Tirzepatide to promote significant weight loss and improve metabolic health.
Non-Invasive Body Sculpting: Advanced technologies like cryolipolysis and EMsculpt Neo to target stubborn fat areas and enhance muscle tone.
Health & Life Coaching: Comprehensive support to help clients build sustainable habits for lasting wellness. bodyevolution-labs.com+2bodyevolution-labs.com+2bodyevolution-labs.com+2
Body Evolution Labs is committed to providing a holistic approach to health and wellness, ensuring clients receive the support they need on their journey to a healthier lifestyle.
For more information or to schedule an appointment, visit bodyevolution-labs.com or contact Ross Lobato at 385-732-4212 or Ross@bodyevolution-labs.com.
About Body Evolution Labs:
Founded by Ross and Shawna Lobato, Body Evolution Labs is a medical spa in Layton, Utah, offering science-backed weight loss and body contouring treatments. The clinic focuses on personalized care, utilizing advanced technologies and FDA-approved medications to help clients achieve their health and aesthetic goals.
Media Contact
Company Name: Body Evolution Labs
Contact Person: Ross Lobato
Email: Send Email
Phone: 385-732-4212
City: Layton
State: UT
Country: United States
Website: bodyevolution-labs.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Post
a day ago
- National Post
iFIT Adds More Ways to Workout, Brings Club Pilates and YogaSix Content to Its Platform
Article content PARK CITY, Utah — iFIT Inc., a global leader in intelligent, personalized fitness, today announced a new partnership with Xponential Fitness to bring iFIT members access to premium Pilates and yoga content from Club Pilates and YogaSix. This collaboration expands iFIT's Emmy-nominated fitness library, offering members more diverse, studio-quality workouts from two of the most popular fitness brands in the boutique space. Article content With this addition, iFIT members can now incorporate Club Pilates and YogaSix classes into their personalized training regimens, supporting a more well-rounded, sustainable, and enjoyable approach to fitness. The content focuses on movements you can do at home on a yoga mat, complementing iFIT's vast library of immersive outdoor content members can enjoy on their treadmill, studio bike, rower or elliptical. Article content 'We're incredibly excited to bring the Club Pilates and YogaSix experiences to our Athletes,' said Jeremy McCarty, Chief Subscription Officer at iFIT Inc. 'As a leader in connected fitness, we're constantly evolving to meet the needs of our Athletes. With this partnership, our Athletes now get access to a broader range of fitness content—all included as part of their iFIT membership.' Article content Meet the New Additions: Article content Club Pilates Article content delivers low-impact, full-body Reformer-based Pilates workouts that strengthen and lengthen the muscles and improve posture. Designed for everyone from beginners to fitness lovers, Club Pilates is ideal for any strength, cross-training, injury recovery, or prenatal or postpartum wellness routine, making it a choice fitness modality for every BODY. Article content YogaSix Article content redefines the yoga experience with modern yoga classes focused on strength, balance, mobility, and mind-body connection. Each class invites participants to grow at their own pace, offering both physical and mental benefits while creating a supportive and energizing community. Article content 'This partnership with iFIT, a pioneer in connected fitness, allows us to bring our world-class content to a wider audience than ever before,' said Steve Pankowski, EVP of Strategic Partnerships at Xponential Fitness. 'By leveraging iFIT's innovative platform and expansive global reach, we're proud to introduce the transformative experiences of Club Pilates and YogaSix to millions of members around the world in a truly immersive, digital-first way.' Article content What's Next: Article content As part of the launch, iFIT will feature Club Pilates and YogaSix classes in a member Challenge, celebrating the new content with fresh opportunities for motivation and progress. Any eligible iFIT member who completes the challenge will receive a Club Pilates intro class pass (in studio) and be entered into a drawing to receive an annual membership to Club Pilates or YogaSix.* Article content About iFIT Inc. Article content iFIT Inc. is a global leader in fitness technology, pioneering connected fitness to help people live longer, healthier lives. With a community of more than 6 million athletes around the world, iFIT delivers immersive, personalized workout experiences at-home, on the go, and in the gym. Powered by a comprehensive ecosystem of proprietary software, innovative hardware, and engaging content, the iFIT platform brings fitness to life through its portfolio of brands: NordicTrack, ProForm, Freemotion, and the iFIT app. From cardio and strength training to recovery, iFIT empowers athletes at every stage of their fitness journey. For more information, visit Article content About Club Pilates & YogaSix Article content Founded in 2007, Club Pilates is the largest Pilates brand by number of studios, designed with the vision of making Pilates more accessible, approachable and welcoming to everyone. Based in Irvine, CA, Club Pilates has appeared in both Entrepreneur Magazine's Franchise 500 and Fastest-Growing Franchises nine years running and Inc. Magazine's Inc. 5000 lists multiple times. Club Pilates offers extensive training certification for its instructors. Its 500-hour training program. Club Pilates is headquartered in Irvine, CA and backed by Xponential Fitness, one of the leading global franchisors of boutique health and wellness brands. To learn more about Club Pilates, visit Article content About YogaSix Article content Founded in 2012, YogaSix is the largest franchised yoga brand in the United States that offers a broad range of heated and non-heated yoga classes, strength-building and cardio-boosting fitness classes, and restorative yoga classes accessible to all. YogaSix has six Signature class formats, including Y6 101, Y6 Restore, Y6 Slow Flow, Y6 Signature Hot and Warm, Y6 Power Flow, and Y6 Sculpt & Flow, plus three Specialty Classes: Y6 Mix, Y6 TRX, and the new Y6 Mobility. Classes at YogaSix eliminate the intimidation factor that many people feel when trying yoga for the first time, offering a fresh perspective on one of the world's oldest fitness practices. Ranked in Entrepreneur Magazine's Franchise 500 three years running, and Fastest-Growing Franchises and Top New Franchises two years running, YogaSix is headquartered in Irvine, California, and backed by Xponential Fitness, one of the leading global franchisors of boutique health and wellness brands. To learn more about YogaSix, visit Article content *NO PURCHASE NECESSARY. Open only to current iFIT subscribers who are residents of the United States or Canada, excluding Quebec; age 18+. Available from June 5, 2025 at 12:01 am MT through July 31, 2025 at 11:59 pm MT. To enter, must complete designated iFIT workouts and submit an entry form prior to July 31, 2025 at 11:59 pm MT. Limit 1 entry and 1 prize per person. Not transferable. Not to be combined with any offer. Subject to Offer Terms. Sponsor: iFIT Inc. Article content Article content Article content
Globe and Mail
a day ago
- Globe and Mail
Should You Invest $1,000 in Eli Lilly today?
Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. The pharma giant's presence across several treatment areas has helped it grow earnings over time. But, in recent years, one particular product portfolio has stood out and driven double-digit revenue growth: drugs to help people lose weight. Right now, Lilly sells tirzepatide, commercialized as Mounjaro for type 2 diabetes and as Zepbound for weight loss, though doctors have prescribed either one for patients hoping to shed pounds. Mounjaro and Zepbound each have become blockbusters, bringing in billion-dollar revenue annually. Lilly dominates the weight loss market along with rival Novo Nordisk, but a recent move by Lilly could help it push farther ahead in the coming years. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Considering this, should you invest $1,000 in Lilly stock today? Let's find out. Lilly's weight loss drugs So, first, let's talk about Lilly's path so far in this market and what might lie ahead. Lilly's weight loss drugs are part of a class known as dual GIP and GLP-1 receptor agonists. They act on hormonal pathways involved in the digestion process and help control blood sugar levels and appetite. Novo Nordisk's rival drug, semaglutide -- sold as Ozempic for type 2 diabetes and Wegovy for weight loss -- targets only GLP-1 but works in a similar way. Novo Nordisk was first to market with its product, winning approval for Ozempic in 2017, and this offered it time to build a market-leading position. But demand has been so high for such weight loss drugs that Lilly quickly gained share soon after entering the market with Mounjaro in 2022 and then with Zepbound in 2023. In fact, demand has been so strong that these drugs held spots on the U.S. Food and Drug Administration's drug shortage list for quite some time, only exiting the list in recent months. A better supply situation for weight loss drugs isn't due to a drop in demand but instead to increases in manufacturing capacity by both companies. So solid demand for these products still exists -- and is likely to grow. Goldman cuts its market forecast It's important to keep in mind, though, that both Lilly and rivals may face some headwinds in the years to come, and that's why Goldman Sachs Research recently reduced its forecast for global sales of anti-obesity medicines to $95 billion by 2030, from an earlier forecast of $130 billion. This is due to several potential challenges, including lower per-unit prices and weaker reimbursement from certain insurers. But even considering the challenges, "we see a significant growth opportunity for both existing players as well as new entrants into this market," said Goldman analyst Asad Haider. After all, from today's $28 billion market, the forecast figure represents a 239% increase. A look at Lilly's weight loss drug sales shows us this company has the momentum to benefit from this high-growth market. Last year, Mounjaro and Zepbound generated more than $11 billion and $4.9 billion in sales, respectively. And these two products are driving double-digit total sales growth at Lilly -- with a 32% gain in the full year and a 45% gain in the most recent quarter. Now, what may push Lilly past Novo Nordisk -- and keep it far ahead of newer rivals down the road -- is the company's progress on an oral weight loss candidate. Current products are in injectable form, which may be less convenient and even uncomfortable for certain users. Lilly recently reported positive results from a phase 3 trial of its oral candidate, orforglipron, and plans to request approval for use in weight management by the end of the year. Though Novo Nordisk sells an oral form of semaglutide, it involves strict food and water guidelines. The potential Lilly product doesn't, offering it a significant advantage. A look at valuation Now, let's return to our question: Should you invest $1,000 in Lilly right now? The shares are trading for 34 times forward earnings estimates -- that's around the same level as top tech companies such as Amazon and Nvidia, also known for delivering double-digit revenue growth. LLY PE Ratio (Forward) data by YCharts In fact, since the launch of tirzepatide, Lilly has traded at valuations resembling those of growth stocks. So it may seem pricey to you for a pharmaceutical player. But it's worth keeping in mind that Lilly stands out from the pharma crowd due to its presence in the high-growth market of weight loss drugs, yet at the same time it offers you the stability and dividend growth of a pharma stock. You generally can count on big pharma companies for steady revenue since patients always need their medicines -- regardless of the economic situation. And you can count on Lilly for passive income too, with a forward dividend of $6, representing a dividend yield of 0.8%. Meanwhile, valuation has come down from its peak to levels that look very acceptable for a growth stock. All of this means that, by investing in Lilly, you're getting growth worthy of a tech company along with the safety generally associated with a pharma stock. That makes the stock well worth the price, and a great place to park $1,000 right now. Should you invest $1,000 in Eli Lilly right now? Before you buy stock in Eli Lilly, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $656,825!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $865,550!* Now, it's worth noting Stock Advisor 's total average return is994% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Adria Cimino has positions in Amazon. The Motley Fool has positions in and recommends Amazon, Goldman Sachs Group, and Nvidia. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy.
Globe and Mail
2 days ago
- Globe and Mail
Ross Lobato Launches Body Evolution Labs: A New Era of Science-Backed Weight Loss and Body Contouring in Layton, Utah
Layton, UT - Ross Lobato, alongside his wife Shawna Stanger Lobato, proudly announces the opening of Body Evolution Labs, a premier medical spa in Davis County dedicated to transformative, non-invasive weight loss and body sculpting solutions. Located at 1454 N Hill Field Rd, Suite #1, Body Evolution Labs offers a range of services designed to help clients achieve their health and aesthetic goals. The clinic specializes in FDA-approved GLP-1 weight loss programs utilizing Semaglutide and Tirzepatide, which have been shown to help clients lose 15–20% of their body weight. "We combine medical insight with real-life results," says Ross Lobato. "No gimmicks, no shortcuts—just proven treatments and personalized care that put your goals front and center." Services Offered: GLP-1 Weight Loss Programs: Personalized plans using Semaglutide and Tirzepatide to promote significant weight loss and improve metabolic health. Non-Invasive Body Sculpting: Advanced technologies like cryolipolysis and EMsculpt Neo to target stubborn fat areas and enhance muscle tone. Health & Life Coaching: Comprehensive support to help clients build sustainable habits for lasting wellness. Body Evolution Labs is committed to providing a holistic approach to health and wellness, ensuring clients receive the support they need on their journey to a healthier lifestyle. For more information or to schedule an appointment, visit or contact Ross Lobato at 385-732-4212 or Ross@ About Body Evolution Labs: Founded by Ross and Shawna Lobato, Body Evolution Labs is a medical spa in Layton, Utah, offering science-backed weight loss and body contouring treatments. The clinic focuses on personalized care, utilizing advanced technologies and FDA-approved medications to help clients achieve their health and aesthetic goals. Media Contact Company Name: Body Evolution Labs Contact Person: Ross Lobato Email: Send Email Phone: 385-732-4212 City: Layton State: UT Country: United States Website:
